PDGFRA and gastrointestinal stromal tumor: For example, a retrospective cohort study of GIST patients with PDGFRA exon 18 mutation showed that 16 GIST patients with D842V mutation received imatinib treatment, and only 2 patients had partial response, indicating that imatinib is not generally applicable to patients with this mutation (40).